Search
for

    Sort by

    Research 391–420 of 1000+

    1. Androgenetic alopecia: An update JAAD International · 2023
    2. Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about? Dermatology and therapy · 2023
    3. Treatment Patterns and Unmet Needs in the Management of Alopecia Areata: Results of a Physician’s Survey in the Middle East Dermatology and therapy · 2023
    4. P64 Efficacy of baricitinib in patients with different degrees of severe alopecia areata: 52-week results from BRAVE-AA1 and BRAVE-AA2 British Journal of Dermatology · 2023
    5. Overview of alopecia areata for managed care and payer stakeholders in the United States Journal of managed care & specialty pharmacy · 2023
    6. ISID1108 - Comparison of ruxolitinib and a collagen-targeted PTH-based hair cycle stimulant on hair follicle counts and hair growth in the C3H/HeJ engrafted mouse model of alopecia areata. 2023
    7. A Promising Efficacy of Tofacitinib in an Adult Patient with Alopecia Areata International Journal of Trichology · 2023
    8. Tofacitinib: A Promising Treatment for Adolescent Alopecia Areata International Journal of Trichology · 2023
    9. Review of efficacy of baricitinib in the treatment of alopecia areata International Journal of Research in Dermatology · 2023
    10. Baricitinib for alopecia areata Journal of Pakistan Medical Association · 2023
    11. Pattern hair loss distribution: a novel presentation for alopecia areata Journal of Dermatological Treatment · 2023
    12. Analyzing the role of tofacitinib in treatment of alopecia areata: A retrospective analysis from a tertiary care center of North India National Journal of Physiology, Pharmacy and Pharmacology · 2023
    13. 32237 Clinician and patient evaluation of improvement for eyebrow and eyelashes hair loss during baricitinib phase 3 trials BRAVE-AA1 and BRAVE-AA2 Journal of The American Academy of Dermatology · 2022
    14. Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape Wound practice & research · 2022
    15. DataSheet1_Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention.PDF Figshare · 2021
    16. Acne exacerbation after tofacitinib treatment for alopecia areata Dermatology Reports · 2021
    17. Updates From 2021 Virtual Dermatology Nurses' Association Convention Journal of the Dermatology Nurses' Association · 2021
    18. Komplet remission ved behandling med JAK-hæmmer hos en patient med alopeciatotalis Research Portal Denmark · 2021
    19. A Novel Hope for Alopecia Totalis Patients: Case Report Dubai medical journal · 2020
    20. Successful treatment of alopecia totalis with tofacitinib in a Danish patient Ugeskrift for Læger · 2020
    21. Medical Therapies Springer eBooks · 2019
    22. The Good and Bad News About New Drugs for Treating Alopecia Areata 2017
    23. PSS20 MEDIATION MODELING AND MEASUREMENT CHARACTERISTICS OF THE ITCH SEVERITY SCORE FROM A PHASE 2B TRIAL OF ORAL CP-690-550 IN PATIENTS WITH MODERATE TO-SEVERE PLAQUE PSORIASIS Value in Health · 2011
    24. Delphi Consensus Statement on Treatment of Severe Alopecia Areata in US Adults JAMA Dermatology · 2026
    25. S3‐Leitlinie Diagnostik und Therapie der Alopecia areata – Teil 2: Therapie, psychosoziale und kosmetische Unterstützung JDDG Journal der Deutschen Dermatologischen Gesellschaft · 2026
    26. When hair dig into the brain, JAKi , may help! Journal of the European Academy of Dermatology and Venereology · 2026
    27. Assessment and treatment of adolescent hair loss Current Opinion in Pediatrics · 2026
    28. HX17 The fortunate side effect: serendipity and therapeutic innovation in dermatology British Journal of Dermatology · 2026
    29. Diagnostic Challenges and Treatment Strategies in Neutrophilic Cicatricial Alopecias: A Narrative Review from Conventional Therapies to New Therapeutic Targets Life · 2026
    30. MODERN TREATMENT APPROACHES FOR ALOPECIA: CURRENT ADVANCES AND FUTURE PERSPECTIVES Zenodo (CERN European Organization for Nuclear Research) · 2026